These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28011346)

  • 1. Bucindolol improves right ventricle function in rats with pulmonary arterial hypertension through the reversal of autonomic imbalance.
    Lima-Seolin BG; Colombo R; Bonetto JHP; Teixeira RB; Donatti LM; Casali KR; Godoy AEG; Litvin IE; Schenkel PC; Rosa Araujo ASD; Belló-Klein A
    Eur J Pharmacol; 2017 Mar; 798():57-65. PubMed ID: 28011346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bucindolol attenuates the vascular remodeling of pulmonary arteries by modulating the expression of the endothelin-1 A receptor in rats with pulmonary arterial hypertension.
    de Lima-Seolin BG; Hennemann MM; Fernandes RO; Colombo R; Bonetto JHP; Teixeira RB; Khaper N; Godoy AEG; Litvin IE; Sander da Rosa Araujo A; Schenkel PC; Belló-Klein A
    Biomed Pharmacother; 2018 Mar; 99():704-714. PubMed ID: 29710468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trapidil improves hemodynamic, echocardiographic and redox state parameters of right ventricle in monocrotaline-induced pulmonary arterial hypertension model.
    Türck P; Lacerda DS; Carraro CC; de Lima-Seolin BG; Teixeira RB; Poletto Bonetto JH; Colombo R; Schenkel PC; Belló-Klein A; da Rosa Araujo AS
    Biomed Pharmacother; 2018 Jul; 103():182-190. PubMed ID: 29653363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a pure alpha/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats.
    Ishikawa M; Sato N; Asai K; Takano T; Mizuno K
    Circ J; 2009 Dec; 73(12):2337-41. PubMed ID: 19822980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension.
    Okumura K; Kato H; Honjo O; Breitling S; Kuebler WM; Sun M; Friedberg MK
    J Mol Med (Berl); 2015 Jun; 93(6):663-74. PubMed ID: 25595602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ovariectomy on antioxidant defence systems in the right ventricle of female rats with pulmonary arterial hypertension induced by monocrotaline.
    Siqueira R; Colombo R; Conzatti A; de Castro AL; Carraro CC; Tavares AMV; Fernandes TRG; Araujo ASDR; Belló-Klein A
    Can J Physiol Pharmacol; 2018 Mar; 96(3):295-303. PubMed ID: 28854338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in pharmacological action of the right ventricle of monocrotaline-induced pulmonary hypertensive rats.
    Daicho T; Yagi T; Takano S; Marunouchi T; Abe Y; Ohara M; Takeo S; Tanonaka K
    Biol Pharm Bull; 2009 Aug; 32(8):1378-84. PubMed ID: 19652377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension.
    de Man FS; Handoko ML; van Ballegoij JJ; Schalij I; Bogaards SJ; Postmus PE; van der Velden J; Westerhof N; Paulus WJ; Vonk-Noordegraaf A
    Circ Heart Fail; 2012 Jan; 5(1):97-105. PubMed ID: 22157723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of inflammation, oxidative stress, and autonomic nervous system activation during the development of right and left cardiac remodeling in experimental pulmonary arterial hypertension.
    Zimmer A; Teixeira RB; Bonetto JHP; Bahr AC; Türck P; de Castro AL; Campos-Carraro C; Visioli F; Fernandes-Piedras TR; Casali KR; Scassola CMC; Baldo G; Araujo AS; Singal P; Belló-Klein A
    Mol Cell Biochem; 2020 Jan; 464(1-2):93-109. PubMed ID: 31728802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Body Surface Potentials in Rats with Experimental Pulmonary Hypertension during Ventricular Depolarization.
    Suslonova OV; Smirnova SL; Roshchevskaya IM
    Bull Exp Biol Med; 2016 Nov; 162(1):7-10. PubMed ID: 27878490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity.
    Alencar AK; Pereira SL; da Silva FE; Mendes LV; Cunha Vdo M; Lima LM; Montagnoli TL; Caruso-Neves C; Ferraz EB; Tesch R; Nascimento JH; Sant'anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Int J Cardiol; 2014 May; 173(2):154-62. PubMed ID: 24630383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of chrysin on expression of NOX4 and NF-κB in right ventricle of monocrotaline-induced pulmonary arterial hypertension of rats].
    Li XW; Guo B; Shen YY; Yang JR
    Yao Xue Xue Bao; 2015 Sep; 50(9):1128-34. PubMed ID: 26757549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats.
    Ahmed LA; Rizk SM; El-Maraghy SA
    Biochem Pharmacol; 2017 Aug; 138():193-204. PubMed ID: 28450224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.